1,2,5,6-dibenzanthracene has been researched along with Fibrocystic Breast Disease in 1 studies
1,2,5,6-dibenzanthracene: RN given refers to parent cpd
Fibrocystic Breast Disease: A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ianysheva, NIa | 1 |
| Chernichenko, IA | 1 |
| Balenko, NV | 1 |
| Litvichenko, ON | 1 |
| Parfenov, IuD | 1 |
| Antomonov, MIu | 1 |
| Rusakova, LT | 1 |
1 other study available for 1,2,5,6-dibenzanthracene and Fibrocystic Breast Disease
| Article | Year |
|---|---|
[Experimental substantiation of MPEL of dibenz(a,n)anthracene in atmospheric air].
Topics: Air Pollutants; Animals; Benz(a)Anthracenes; Carcinogens; Dose-Response Relationship, Drug; Female; | 1990 |